# Compare the Immune Response & Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine vs Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis & Dialysis Patients Who Did Not Respond to Previous Hepatitis B Vaccination

> **NCT00291954** · PHASE3 · COMPLETED · sponsor: **Henogen** · enrollment: 257 (actual)

## Conditions studied

- Hepatitis B

## Interventions

- **BIOLOGICAL:** HB-AS02V
- **BIOLOGICAL:** HBVAXPRO vaccine

## Key facts

- **NCT ID:** NCT00291954
- **Lead sponsor:** Henogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2007-10
- **Final completion:** 2007-10
- **Target enrollment:** 257 (ACTUAL)
- **Last updated:** 2008-08-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00291954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00291954, "Compare the Immune Response & Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine vs Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis & Dialysis Patients Who Did Not Respond to Previous Hepatitis B Vaccination". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00291954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*